Company intelligence / Profile preview

InfuTronix Solutions

Natick, Massachusetts, United States

Ownership: Private
Employees: ~88
Development stage: Other

Overview

InfuTronix Solutions developed and commercialized ambulatory infusion pump systems including the Nimbus and Nimbus II lines for applications in pain management, chemotherapy, and chronic disease management. The company issued a voluntary Class I recall of Nimbus infusion pump systems in February 2024 due to multiple device failures, with products no longer supported after June 20, 2024.

Therapeutic areas: OncologyNeurologyOther
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Geo-Med

Beyond the preview

Go deeper on InfuTronix Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InfuTronix Solutions.

Explore the full profile